Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PXE | 27.18 | 0.47 | +1.76% |
| Invesco Energy Exploration & Prod ETF | |||
| GINN | 61.93 | 0.46 | +0.76% |
| Goldman Sachs Innovate Equity ETF | |||
| FAPR | 41.44 | 0.18 | +0.43% |
| FT Vest US Equity Buffer ETF Apr | |||
| EMM | 25.55 | 0.06 | +0.24% |
| Global X Emerging Markets ex-China ETF | |||
| SPTS | 29.11 | -0.02 | -0.07% |
| SPDR® Portfolio Short Term Treasury ETF | |||
A.I.dvisor tells us that POLBF and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and NNVC's prices will move in lockstep.
| Ticker / NAME | Correlation To POLBF | 1D Price Change % | ||
|---|---|---|---|---|
| POLBF | 100% | N/A | ||
| NNVC - POLBF | 26% Poorly correlated | -3.79% | ||
| BOLT - POLBF | 26% Poorly correlated | -3.11% | ||
| BEIGF - POLBF | 25% Poorly correlated | N/A | ||
| DSGN - POLBF | 25% Poorly correlated | -3.91% | ||
| ALXO - POLBF | 22% Poorly correlated | -19.08% | ||
More | ||||